Neossance Hemisqualane
| Source | SynBio Database |
|---|---|
| Organization | Aprinnova |
| Market status | On the market |
| Industry | Health |
| Value chain stage | Finished Product |
| Intended consumer | Consumer |
| Production process | Closed Production |
| Business models | B2C |
| Product categories | Personal Care (Topical) |
| Biotech components | Plant |
| Organization type(s) | Public Company |
| Funding types | Shareholder Investment |
| Known funding amount | $471,900,000 USD |
| Country of production | USA |
| Country of distribution | USA + Japan + Europe |
| Trading symbol | AMRS |
| Trading exchange | NASDAQ |
| Notes | Joint venture of Amyris and NIKKOl Group |
| Additional link #1 | investors.amyris.com/news-releases/news-release-det… |